Compare MPAA & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPAA | ACHV |
|---|---|---|
| Founded | 1968 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.3M | 233.2M |
| IPO Year | 2007 | 2018 |
| Metric | MPAA | ACHV |
|---|---|---|
| Price | $11.06 | $2.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $17.50 | $15.50 |
| AVG Volume (30 Days) | 107.0K | ★ 698.9K |
| Earning Date | 02-09-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.56 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $757,354,000.00 | N/A |
| Revenue This Year | $1.50 | N/A |
| Revenue Next Year | $7.42 | $578.60 |
| P/E Ratio | $83.54 | ★ N/A |
| Revenue Growth | ★ 5.53 | N/A |
| 52 Week Low | $8.17 | $1.84 |
| 52 Week High | $18.12 | $6.03 |
| Indicator | MPAA | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 31.14 |
| Support Level | $9.60 | $2.90 |
| Resistance Level | $12.57 | $3.39 |
| Average True Range (ATR) | 0.42 | 0.26 |
| MACD | 0.13 | -0.13 |
| Stochastic Oscillator | 83.10 | 16.86 |
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.